W7R-72813-39139
3 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 310 / GA
- Registered
- 2021-11-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Moderna
-
2021-02-26
Dose 2 — Moderna
-
2021-11-18
Dose 3 — Moderna
-
2021-11-22
Registered in v-safe
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-12-02
-
2022-05-21
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain, Upper respiratory tract congestion — Feeling: GoodFree text: Sore throat and upper respiratory congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | No |
| 2 | 2021-02-26 | Moderna | No |
| 3 | 2021-11-18 | Moderna | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Sore throat and upper respiratory congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Upper respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release